Nanchang University
20
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 20 trials
100.0%
+13.5% vs industry average
20%
4 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (20)
Comorbidity-Oriented Primary Care and Integrated Management for Hypertension and Diabetes Mellitus
Role: lead
A Prospective Single-center Randomized Controlled Trial of Robotic Surgery With Transrectal Resection Specimens (NOSES-IV) and Traditional Assisted Robotic Surgery for the Treatment of High Rectal and Sigmoid Colon Cancer
Role: lead
Robotic Natural Orifice Specimen Extraction Surgery Compared to Robotic Assisted Surgery for Median Rectal Cancer
Role: lead
The Application Value of da Vinci Linear Cutting Stapler SureForm in Robotic Anus Preserving Surgery for Rectal Cancer
Role: lead
External Application of Mirabilite to Promote Recovery in Patients After Gastrointestinal Surgery
Role: lead
Raspberry Ketone Intake Upregulates Circulating FGF21 and Induces Energy Expenditure in Humans
Role: lead
Prevalence and Risk Indicators of Peri-implant Diseases in China
Role: collaborator
Routine Lymphadenectomy for Intrahepatic Cholangiocarcinoma
Role: collaborator
Osimertinib With Bevacizumab for Leptomeningeal Metastasis From EGFR-mutation Non-Small Cell Lung Cancer
Role: collaborator
Gefitinib With Anlotinib in Advanced Non-squamous NSCLC Patients With Uncleared Plasma ctDNA EGFRm After First-line Treatment With Gefitinib
Role: collaborator
The Role of Brain Radiotherapy in Patients With Asymptomatic Brain Metastasis in the Era of Targeted Therapy for NSCLC
Role: collaborator
Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis
Role: collaborator
The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg
Role: collaborator
The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAg
Role: collaborator
HBsAg Loss/Seroconversion in Low Replicative Chronic Hepatitis B Virus(HBV) Infection Patients
Role: collaborator
Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine
Role: collaborator
Repeatability and Agreement of Anterior Segment Optical Coherence Tomography (AS-OCT) and Thermography
Role: collaborator
Treatment for HBV-MN Patients in Chinese: An Open Parallel Controlled Trial
Role: lead
Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids
Role: collaborator
5FU vs 5FU With Viscoelastic Formulation for the Prevention of Scarring Post-trabeculectomy
Role: collaborator
All 20 trials loaded